Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
829
|
70
|
0.550 |
None |
1.000 |
3 |
|
2001 |
2010 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2395
|
676
|
0.460 |
None |
0.909 |
6 |
1
|
2009 |
2019 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1105
|
238
|
0.360 |
None |
0.857 |
6 |
|
2006 |
2016 |
Nodular Lymphocyte Predominant Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
43
|
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2015 |
Adult Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
396
|
27
|
0.310 |
None |
1.000 |
1 |
|
2003 |
2010 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1679
|
213
|
0.120 |
None |
1.000 |
2 |
|
2011 |
2017 |
B-Cell Lymphomas
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1375
|
42
|
0.100 |
None |
1.000 |
14 |
1
|
1996 |
2016 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10153
|
1571
|
0.090 |
None |
1.000 |
9 |
|
1996 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8577
|
1441
|
0.090 |
None |
1.000 |
9 |
|
2004 |
2019 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1020
|
109
|
0.070 |
None |
1.000 |
7 |
|
1996 |
2015 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1460
|
76
|
0.070 |
None |
0.857 |
5 |
|
2003 |
2015 |
Classical Hodgkin's Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
285
|
20
|
0.050 |
None |
1.000 |
5 |
|
2002 |
2016 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.050 |
None |
1.000 |
5 |
|
2006 |
2019 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.040 |
None |
0.750 |
4 |
|
2007 |
2015 |
Adult Classical Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
233
|
10
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2007 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6241
|
355
|
0.040 |
None |
0.750 |
4 |
|
1999 |
2019 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.040 |
None |
0.750 |
4 |
|
2007 |
2015 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1686
|
635
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2013 |
Arthritis, Psoriatic
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
414
|
50
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2014 |
Adult Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
501
|
42
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2015 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.020 |
None |
0.500 |
2 |
|
1996 |
2006 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
756
|
47
|
0.020 |
None |
1.000 |
2 |
|
1996 |
2010 |
Lymphoma, Follicular
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
459
|
60
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2017 |
Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1358
|
125
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2007 |
Ulcerative Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1277
|
392
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2011 |